Elderly recipients of hepatitis c positive renal allografts can quickly develop liver disease

Journal of Surgical Research

Volumn 176, Issue 2, 2012, Pages 629-638

  Flohr, Tanya R ^a   Bonatti, Hugo ^b   Hranjec, Tjasa ^a   Keith, Doug S ^a   Lobo, Peter I ^a   Kumer, Sean C ^a   Schmitt, Timothy M ^a   Sawyer, Robert G ^a   Pruett, Timothy L ^c   Roberts, John P ^d   Brayman, Kenneth L ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

elderly; end stage renal disease; HCV; hepatitis C; infectious diseases; kidney transplant

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN;

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE COURSE; FAILURE TO THRIVE; FEMALE; FOLLOW UP; GLOMERULONEPHRITIS; GRAFT RECIPIENT; HEART INFARCTION; HEPATITIS C; HUMAN; HYPERTENSION; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY ALLOGRAFT; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; LIVER BIOPSY; LIVER DISEASE; LYMPHOCELE; MALE; MORBIDITY; MORTALITY; MULTIPLE ORGAN FAILURE; NON INSULIN DEPENDENT DIABETES MELLITUS; OROPHARYNX CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; PYELONEPHRITIS; RETROSPECTIVE STUDY; SEPSIS; SEROLOGY; VIRUS LOAD; WEGENER GRANULOMATOSIS;

ADULT; AGE FACTORS; AGED; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HEPATITIS C; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MORBIDITY; POSTOPERATIVE COMPLICATIONS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 84863982457     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2011.10.028     Document Type: Article

References (45)

1. United States Renal Data System 2007. Annual Data Report Am J Kidney Dis 2008
2. W.W. Brown Hemodialysis in elderly patients Int Urol Nephrol 32 2000 127
3. P.S. Rao, R.M. Merion, and V.B. Ashby Renal transplantation in elderly patients older than 70 years of age: Results from the scientific registry of transplant recipients Transplantation 83 2007 1069
4. R.A. Wolfe, V.B. Ashby, and E.L. Milford Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant N Engl J Med 341 1999 1725
5. Organ Procurement and Transplantation Network/United Network for Organ Sharing data. 2009.
6. C.E. Stevens, P.E. Taylor, and J. Pindyck Epidemiology of hepatitis C virus: A preliminary study in volunteer blood donors JAMA 263 1990 49
7. S.N. Natov Transmission of viral hepatitis by kidney transplantation: Donor evaluation and transplant policies (Part 1: Hepatitis B virus) Transpl Infect Dis 4 2002 124
8. D.M. Cahane, A. Barak, and O. Goller The incidence of hepatitis C virus positive serological test results among cornea donors Cell Tissue Bank 11 2000 81
9. B.M. Eggen, and S.A. Nordbo Transmission of HCV by organ transplantation N Engl J Med 326 1992 412
10. K.C. Abbott, K.L. Lentine, and J.R. Bucci The impact of transplantation with deceased donor hepatitis C positive kidneys on survival in wait-listed long-term dialysis patients Am J Transpl 4 2004 2032
11. G.M. Lauer, and B.D. Walker Hepatitis C virus infection N Engl J Med 345 2001 41
12. K.C. Abbott, J.R. Bucci, and C.S. Matsumoto Hepatitis C and renal transplantation in the era of modern immunosuppression J Am Soc Nephrol 14 2003 2908
13. M. Berenguer, J. Crippin, and R. Gish A model to predict severe HCV-related disease following liver transplantation Hepatology 38 2003 34
14. M.A. Serra, F. Rodriguez, and J.A. del Olmo Influence of age and date of infection on distribution of hepatitis C virus genotypes and fibrosis stage J Viral Hepat 10 2003 183
15. N.N. Selzner, N. Girgrah, and L. Lilly The difference in the fibrosis progression of recurrent hepatitis C after live donor liver transplantation versus deceased donor liver transplantation is attributable to the difference in donor age Liver Transpl 14 2008 1778
16. V.I. Machicao, H. Bonatti, and M. Krishna Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C Transplantation 77 2004 84
17. M. Berenguer, M. Prieto, and F. San Juan Contribution of donor age to the recent decrease in patient survival among HCV infected liver transplant recipients Hepatology 36 2002 202
18. M. Wali, R.F. Harrison, and P.J. Gow Advancing donor liver age and repaid fibrosis progression following transplantation for Hepatitis C Gut 51 2002 248 252 (Pubitemid 34791456)
19. J.P. Neuman, T. Berg, and M. Bahra Fibrosis progression after liver transplantation in patients with recurrent hepatitis C J Hepatol 41 2004 830
20. S.C. Rayhill, Y.M. Wu, and D.A. Katz Older donor livers show early severe histological activity, fibrosis and graft failure after liver transplantation for hepatitis C Transplantaion 84 2007 331
21. R.G. Knodell, K.G. Ishak, and W.C. Black Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis Hepatology 1 1981 431
22. B.J. Pereira, T.L. Wright, and C.H. Schmid A controlled study of hepatitis C transmission by organ transplantation Lancet 345 1995 484
23. P. Marcellin Hepatitis C: The clinical spectrum of the disease J Hepatol 31 1999 9
24. A. Maheshwari, S. Ray, and P.J. Thuluvath Acute hepatitis C Lancet 372 2008 321
25. T. Poynard, V. Ratziu, and Y. Benhamou Natural history of HCV infection Baillière's Best Pract Res Clin Gastroenterol 14 2000 211
26. T. Poynard, P. Bedossa, and P. Opolon Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups Lancet 22 1997 825
27. M. Nakagawa, N. Sakamoto, and Y. Tanabe Suppression of hepatitis C virus replication by cyclosporin A is mediated by blockade of cyclophilins Gastroenterology 129 2005 1031
28. L.L. Schiavon, R.J. Carvalho-Filho, and J.L. Narciso-Schiavon Impact of cyclosporine-based Hepatology 48 2008 348
29. H.U. Meier-Kriesche, and B. Kaplan Immunosuppression in elderly renal transplant recipients: Are current regimens to aggressive? Drugs Aging 18 2001 751
30. G.M. Danovitch, J. Gill, and S. Bunnapradist Immunosuppression of the elderly kidney transplant receipient Transplantation 84 2007 285 291 (Pubitemid 47258313)
31. H.U. Meier-Kriesche, A.O. Ojo, and J.A. Arndorfer Need for individualized immunosuppression in elderly renal transplant recipients Transpl Proc 33 2001 1190
32. H.U. Meier-Kriesche, A. Ojo, and J. Hanson Increased immunosuppressive vulnerability in elderly renal transplant recipients Transplantation 69 2000 885
33. V. Lufft, V. Kliem, and G. Tusch Renal transplantation in older adults: Is graft survival affected by age? A case control study Transplantation 69 2000 790
34. H.B. El-Serag, B. Anand, and P. Richardson Association between hepatitis C infection and other infectious diseases: A case for targeted screening? Am J Gastroenterol 98 2003 167
35. D. Roth, K. Zucker, and R. Cirocco The impact of hepatitis C virus infection on renal allograft recipients Kidney Int 45 1994 238
36. N. Singh, T. Gayowski, M.M. Wagener, and I.R. Marino Increased infections in liver transplant recipients with recurrent hepatitis C virus hepatitis Transplantation 61 1996 402
37. M.P. LaQuaglia, N.E. Tolkoff-Rubin, and J.L. Dieustag Impact of hepatitis on renal transplantation Transplantation 32 1981 504
38. G.T. Everson Impact of immunosuppressive therapy on recurrence of hepatitis C Liver Transpl 8 2002 S19
39. A.K. Burroughs Induction immunosuppression for patients who underwent transplantation for cirrhosis caused by hepatitis C? The answer is no! Liver Transpl 8 2002 S47
40. J.D. Eason, S. Nair, and A.J. Cohen Steroid-free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy Transplantation 75 2003 1396
41. T.F. Fuller, S.M. Kang, and R. Hirose Management of lymphoceles after renal transplantation: Laparoscopic versus open drainage J Urol 169 2003 2022
42. R.J. Howard, R.L. Simmons, and J.S. Najarian Prevention of lymphoceles following renal transplantation Ann Surg 184 1976 166
43. G. Bischof, S. Rockenschaub, and G. Berlakovich Management of lymphoceles after kidney transplantation Transpl Int 11 1998 277
44. T. Kasprzyk, A. Kwiatkowski, and M. Wszola Long-term results of kidney transplantation from HCV-positive donors Transplant Proc 39 2007 2701
45. P. Veroux, M. Veroux, and V. Sparacino Kidney transplantation from donor with viral B and C hepatitis Transplant Proc 38 2006 996